Drug Discovery Biology
Cardiogenesis Unraveled: Using Organoids to Study Human Heart Biology
Organoids, including epicardioids, provide promising insights into human heart development and illnesses. Retinoic acid signaling modifications offer new molecular insights. These advancements can lead to better treatments for heart disorders and other conditions.
Unlocking Stem Cell Pluripotency Yields Thymic Organoids
Scientists have made thymic organoids from human pluripotent stem cells that look like the human thymus gland, and this may help study thymic development, interactions and create personalized immunotherapies.
Quotient Sciences and the Quest for Quickening Chemical to Clinical
In a continued quest of quickening chemical production to clinical application, Quotient Sciences expands its oral-dosage form formulation development capabilities via its novel Nottingham facility.
Molecular Modeling Advancements Seen in CD ComputaBio’s Latest Software Suites
Latest molecular docking software suites shown to advance computational biology efforts of CD ComputaBio.
2021: Highlights in Drug Launches
A collection of the most groundbreaking and novel drugs to launch in 2021 – highlighting the innovation in the industry.
Drug Discovery and Quantum Computing
A brief overview of drug discovery and the role Quantum Computing could play in it.
Trends in Peptide Drug Discovery
Oncology and neurology are two therapeutic areas in particular, which are benefiting from peptide drug discovery.Â
